<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00862160</url>
  </required_header>
  <id_info>
    <org_study_id>T201E1</org_study_id>
    <nct_id>NCT00862160</nct_id>
  </id_info>
  <brief_title>Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit</brief_title>
  <acronym>ROCsafeTM</acronym>
  <official_title>Acute Cerebrovascular Events During Extracorporeal Circulation a Comparison of New Minimized Perfusion Circuit to Standard Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Städtisches Klinikum Braunschweig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Terumo Europe N.V.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prospective, randomized, two centre study investigates acute cerebrovascular events
      during extracorporal circulation and the early post operative outcome when using either the
      minimized cardiopulmonary bypass circuit (ROCsafeTM) or a standard cardiopulmonary bypass
      circuit in patients undergoing coronary artery bypass grafting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery bypass grafting with extracorporal circulation is established as the golden
      standard. The conventional cardiopulmonary bypass (CPB) system is associated with
      inflammatory reaction, hemolysis, hemodilution an disturbances of the blood coagulation
      system. Also it's well known that neurological disturbances caused by embolic material and
      air bubbles are potential risks of CPB. The new minimized perfusion circuit ROCsafeTM is a
      closed, reservoir-less, reduced prime, surface coated circuit, with optimized safety features
      in effectively eliminate both macro and micro air bubbles and should optimize the clinical
      outcome after CABG using cardiopulmonary bypass.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fresh micro-lesions in cranial MRT</measure>
    <time_frame>before and 72 h after CABG</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>30 days after CABG</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological events</measure>
    <time_frame>between CABG and discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurocognitive function</measure>
    <time_frame>before and 3-4 days after CABG and after 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Acute Cerebrovascular Accident</condition>
  <condition>Intracranial Embolism</condition>
  <condition>Embolism, Air</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>using minimized cardiopulmonary bypass circuit ROCsafeTM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>using standard cardiopulmonary bypass circuit</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ROCsafeTM</intervention_name>
    <description>using minimized perfusion circuit while CABG</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is older than 17 years

          -  Patient is acceptable candidate for CABG operation

          -  Patient or the patient's legal representative has been informed of the nature of the
             study and agrees to its provisions and has provided written informed consent.

        Exclusion Criteria:

          -  Ejection fraction less than 30 %

          -  Valve surgery

          -  Acute endocarditis or history of endocarditis

          -  Cerebral ischemia within 4 weeks before surgery

          -  Detection of intracardial thrombi in preoperative echocardiography

          -  Stenosis of A. carotis int. greater than 70 %

          -  Patients older than 80 years

          -  Patients on dialysis

          -  Acute myocardial ischemia or infarction within two weeks before inclusion

          -  Markedly elevated baseline C-reactive protein (CRP) or leucocytosis

          -  Cancer or immunologic diseases

          -  Dysregulation of the coagulation cascade (not concerning INR or PTT under cumarin or
             heparin treatment)

          -  Intake of steroids or NSAR

          -  Female of childbearing potential

          -  Participation in an other study

          -  Contraindication for MRI (e.g. pacemaker, any kind of implanted metal)

          -  Claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingo Kutschka, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingo Kutschka, PD Dr. med.</last_name>
    <phone>0049-511-532-2154</phone>
    <email>kutschka.ingo@mh-hannover.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum Braunschweig, Department of Cardiothoracic Surgery</name>
      <address>
        <city>Braunschweig</city>
        <zip>38126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Harringer, PD Dr. med.</last_name>
      <phone>0049-531-595-2213</phone>
      <email>w.harringer@klinikum-braunschweig.de</email>
    </contact>
    <contact_backup>
      <last_name>Aschraf El Essawi, Dr. med.</last_name>
      <phone>0049-531-595-2213</phone>
      <email>a.elessawi@klinikum-braunschweig.de</email>
    </contact_backup>
    <investigator>
      <last_name>Wolfgang Harringer, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uwe Schönrock</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aschraf El Essawi, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School, Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Kutschka, PD Dr. med.</last_name>
      <phone>0049-511-532-2154</phone>
      <email>kutschka.ingo@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Christian Hagl, PD Dr. med.</last_name>
      <phone>0049-511-532-3447</phone>
      <email>hagl.christian@mh-hannover.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ingo Kutschka, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Hagl, PD Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Haverich, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2009</study_first_submitted>
  <study_first_submitted_qc>March 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2009</study_first_posted>
  <last_update_submitted>October 6, 2009</last_update_submitted>
  <last_update_submitted_qc>October 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2009</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. med. Ingo Kutschka</name_title>
    <organization>HannoverMS, Clinic of Cardiac Thoracic Transplantation and Vascular Surgery</organization>
  </responsible_party>
  <keyword>coronary artery bypass surgery</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>heart lung machine</keyword>
  <keyword>acute cerebrovascular event</keyword>
  <keyword>intracranial embolism</keyword>
  <keyword>embolism, air</keyword>
  <keyword>outcome assessment (health care)</keyword>
  <keyword>neuropsychological tests</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>saccadic eye movement test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Intracranial Embolism</mesh_term>
    <mesh_term>Embolism, Air</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

